+218.1%
MRNA vs PAAS
+195.7%
+22.5%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | PAAS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.6% | -2.9% | -3.2% |
| 7D | -12.1% | -8.9% | -3.2% | -8.4% |
| 30D | -1.3% | -11.4% | +10.1% | +4.5% |
| 3M | +250.9% | -20.4% | +271.4% | +288.9% |
| 6M | +343.0% | -40.7% | +383.7% | +420.4% |
| YTD | +657.4% | -26.9% | +684.4% | +748.3% |
| 1Y | +794.9% | -3.1% | +798.0% | +853.1% |
| 3Y | +218.1% | +199.3% | +18.9% | +157.5% |
| All | +218.1% | +195.7% | +22.5% | +157.5% |
Cumulative growth
Daily Returns
Daily percentage return beside PAAS.
Daily Out/Under-Performance
Portfolio return minus PAAS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PAAS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded PAAS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling